ANDROGENETIC ALOPECIA
Clinical trials for ANDROGENETIC ALOPECIA explained in plain language.
Never miss a new study
Get alerted when new ANDROGENETIC ALOPECIA trials appear
Sign up with your email to follow new studies for ANDROGENETIC ALOPECIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hair loss gel shows promise in early trial
Disease control CompletedThis study tested a new gel called PP405 for common hair loss (androgenetic alopecia) in 78 adults aged 18-55. The goal was to check safety and how the body processes the gel over 28 days, with an extra 3-month open-label phase. Participants applied the gel or a placebo daily, an…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE2 • Sponsor: Pelage Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 11:57 UTC
-
New hair loss gel passes first safety check
Symptom relief CompletedThis early-stage study tested the safety of a new topical gel called AH-001 in 64 healthy volunteers and men with male pattern baldness. Participants received either the gel or a placebo to check for side effects and how the drug moves through the body. The goal was to see if hig…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE1 • Sponsor: AnHorn Medicines Co. Ltd. • Aim: Symptom relief
Last updated May 26, 2026 12:04 UTC
-
New antiseptic cocktail may boost hair transplant recovery
Symptom relief CompletedThis study tested whether adding an antibiotic (rifampicin) to a standard antiseptic (povidone-iodine) could better prevent infections and speed up healing after hair transplant surgery. 65 adults were split into two groups: one got the combined solution, the other got the standa…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: NA • Sponsor: Elif Asena KANTARCI • Aim: Symptom relief
Last updated May 26, 2026 11:57 UTC
-
Can a shampoo really help hair loss? new study says maybe
Symptom relief CompletedThis study looked at whether a special shampoo can reduce hair loss in adults with telogen effluvium or mild androgenetic alopecia. Forty people used the shampoo for 3 months. Researchers measured changes in hair length and thickness to see if the product helped.
Matched conditions: ANDROGENETIC ALOPECIA
Sponsor: Lacer S.A. • Aim: Symptom relief
Last updated May 26, 2026 11:09 UTC